Elena Prokupets, Director at C4 Therapeutics, Inc. (CCCC), sold 28,814 shares at $45.16 ($1.3M) on 2021-08-03, disclosed to the SEC on 2021-08-05.
Open-market sale of $1.3M CCCC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.16 | 14,407 | $651K | 50.0% |
| 2 | $45.16 | 14,407 | $651K | 50.0% |
| Total | $45.16 avg | 28,814 | $1.3M | 100% |
| Filing → |
| CCCC | SELL | 2021-09-21 | $2.1M | — | Filing → |
| CCCC | SELL | 2021-09-16 | $6.4M | — | Filing → |
| CCCC | SELL | 2021-09-14 | $527K | — | Filing → |